Castle Biosciences
Castle Biosciences offers a variety of prognostic and diagnostic tests, including gene expression profiling and pharmacogenomics, with CLIA-certified laboratories in Arizona and Pennsylvania.
Services
Castle Biosciences offers a range of prognostic and diagnostic tests tailored to various medical needs. Their products include DecisionDx-Melanoma, DecisionDx-SCC, TissueCypher, and DecisionDx-UM, each designed for specific cancer types. In addition to oncology diagnostics, the company provides pharmacogenomic testing with IDgenetix, which guides medication management for mental health conditions. These services are built on a foundation of gene expression profiling, spatial biology, and pharmacogenomics technologies, aiming to deliver precise and actionable medical insights.
Laboratories
Castle Biosciences operates CLIA-certified and CAP-accredited laboratories in Phoenix, Arizona, and Pittsburgh, Pennsylvania. These laboratories are equipped with advanced technologies to support the development and execution of their diagnostic tests. The certification and accreditation ensure that the labs adhere to high standards of quality and reliability, crucial for accurate diagnostic and prognostic testing.
Clinical Studies
The company has conducted clinical studies involving over 20,000 patients to validate the utility and efficacy of its tests. These studies play a critical role in establishing the clinical relevance of their diagnostic and prognostic tools. The extensive patient involvement underscores the robustness and credibility of the tests offered by Castle Biosciences, enhancing their acceptance and use in clinical practice.
Patient Assistance Program
To ensure accessibility of their diagnostic tests regardless of financial status, Castle Biosciences offers a patient assistance program. This initiative is designed to reduce financial barriers for patients, making it possible for more individuals to benefit from their advanced diagnostic and prognostic tests. The program reflects the company's commitment to patient care and support.
Environmental, Social, and Governance (ESG) Initiatives
Castle Biosciences engages in various ESG initiatives, emphasizing their values of integrity, transparency, collaboration, and innovation. These initiatives encompass their commitment to ethical business practices, responsible environmental stewardship, and positive social impact. By focusing on these areas, the company aligns its operations with broader societal and environmental goals, demonstrating a commitment to sustainable and responsible business practices.